Unity Biotechnology Correlations
UBX Stock | USD 1.83 0.13 7.65% |
The current 90-days correlation between Unity Biotechnology and Hookipa Pharma is 0.19 (i.e., Average diversification). The correlation of Unity Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Unity |
Moving together with Unity Stock
0.89 | PLX | Protalix Biotherapeutics | PairCorr |
0.81 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
0.79 | GE | GE Aerospace | PairCorr |
0.8 | MMM | 3M Company | PairCorr |
0.71 | JPM | JPMorgan Chase | PairCorr |
Moving against Unity Stock
0.74 | CDIO | Cardio Diagnostics | PairCorr |
0.7 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.4 | ELVN | Enliven Therapeutics | PairCorr |
0.37 | CDIOW | Cardio Diagnostics | PairCorr |
0.32 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.5 | MRK | Merck Company | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Unity Stock performing well and Unity Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Unity Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EXAI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RXRX | 4.88 | 0.32 | 0.03 | 0.04 | 5.80 | 8.87 | 36.13 | |||
AVIR | 1.80 | 0.19 | 0.10 | 0.37 | 1.99 | 5.05 | 10.38 | |||
ICVX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
HOOK | 3.63 | (0.68) | 0.00 | (5.15) | 0.00 | 7.00 | 32.80 | |||
ABOS | 2.99 | (0.64) | 0.00 | (0.59) | 0.00 | 6.57 | 19.77 | |||
HRTX | 3.86 | 0.79 | 0.20 | 0.77 | 3.47 | 7.98 | 29.80 | |||
FIXX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RNA | 2.83 | 0.07 | 0.00 | (0.02) | 0.00 | 6.64 | 20.15 | |||
BEAM | 3.44 | (0.10) | 0.00 | (0.15) | 0.00 | 7.58 | 23.04 |
Unity Biotechnology Corporate Management
Dr AB | CoFounder Director | Profile | |
Nathan Guz | Vice Operations | Profile | |
Judith Campisi | Founder | Profile | |
Daohong MD | Founder | Profile | |
Anirvan Ghosh | CEO Director | Profile | |
Jamie MD | Chief Officer | Profile |